What are BAX's business segments?

Baxter International Inc. (BAX) reports revenue by product line and geographic region in its 10-K segment disclosures. The composition lists on this page show the most recent breakdown; the expanded table view shows the multi-year transposed history.

Which segment generates the most revenue for BAX?

Baxter International Inc.'s largest reported segment is Medical Products And Therapies, at $5.30 billion in revenue for fiscal year 2025 (ended December 31, 2025). It sits at the top of the composition list on this page. Segment mix can shift materially year over year, especially after acquisitions, divestitures, or new-product launches — the expand-modal view shows the full trajectory.

How current is BAX's segment data?

Baxter International Inc. (BAX)'s segment breakdown on this page is from its most recent annual filing, fiscal year 2025 (ended December 31, 2025). Segment disclosures are reported annually in the 10-K and refresh within 48 hours of each filing.

BAX

Baxter International Inc.

NYSE·Medical, Instruments & Supplies · Healthcare

$22.21$0.14+0.63%

After hours·$22.00−0.95%

Market cap$11.47B·Market closed·Jul 21 8:00 PM UTC

Frequently Asked Questions About BAX

What are BAX's business segments?: Baxter International Inc. (BAX) reports revenue by product line and geographic region in its 10-K segment disclosures. The composition lists on this page show the most recent breakdown; the expanded table view shows the multi-year transposed history.
Which segment generates the most revenue for BAX?: Baxter International Inc.'s largest reported segment is Medical Products And Therapies, at $5.30 billion in revenue for fiscal year 2025 (ended December 31, 2025). It sits at the top of the composition list on this page. Segment mix can shift materially year over year, especially after acquisitions, divestitures, or new-product launches — the expand-modal view shows the full trajectory.
How current is BAX's segment data?: Baxter International Inc. (BAX)'s segment breakdown on this page is from its most recent annual filing, fiscal year 2025 (ended December 31, 2025). Segment disclosures are reported annually in the 10-K and refresh within 48 hours of each filing.

BAX

Baxter International Inc.

NYSE·Medical, Instruments & Supplies · Healthcare

$22.21$0.14+0.63%

After hours·$22.00−0.95%

Market cap$11.47B·Market closed·Jul 21 8:00 PM UTC

By Product

Latest period2025

Segment	Revenue	Share	YoY Growth %
Medical Products And Therapies	$5.30B	48.8%	+1.8%
Healthcare Systems and Technologies	$3.07B	28.3%	+4.1%
Pharmaceuticals	$2.49B	22.9%	+3.4%

By Geography

Latest period2025

Segment	Revenue	Share	YoY Growth %
UNITED STATES	$6.12B	54.4%	+4.6%
Western Europe, Canada, Japan, Australia and New Zealand	$3.73B	33.2%	+8.5%
EMEA	$1.39B	12.4%	+3.3%

Frequently Asked Questions About BAX

What are BAX's business segments?: Baxter International Inc. (BAX) reports revenue by product line and geographic region in its 10-K segment disclosures. The composition lists on this page show the most recent breakdown; the expanded table view shows the multi-year transposed history.
Which segment generates the most revenue for BAX?: Baxter International Inc.'s largest reported segment is Medical Products And Therapies, at $5.30 billion in revenue for fiscal year 2025 (ended December 31, 2025). It sits at the top of the composition list on this page. Segment mix can shift materially year over year, especially after acquisitions, divestitures, or new-product launches — the expand-modal view shows the full trajectory.
How current is BAX's segment data?: Baxter International Inc. (BAX)'s segment breakdown on this page is from its most recent annual filing, fiscal year 2025 (ended December 31, 2025). Segment disclosures are reported annually in the 10-K and refresh within 48 hours of each filing.